Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genome Editing Market Trends and Forecast
3.3: Global Genome Editing Market by Technology
3.3.1: CRISPR/Cas9
3.3.2: TALENs
3.3.3: ZFN
3.3.4: Others
3.4: Global Genome Editing Market by Delivery Method
3.4.1: Ex-Vivo
3.4.2: In-Vivo
3.5: Global Genome Editing Market by Application
3.5.1: Cell Line Engineering
3.5.2: Animal Genetic Engineering
3.5.3: Plant Genetic Engineering
3.5.4: Other Applications
3.6: Global Genome Editing Market by Service
3.6.1: Contract
3.6.2: In-House
3.7: Global Genome Editing Market by End Use
3.7.1: Biotechnology & Pharmaceutical Companies
3.7.2: Academic & Government Research Institutes
3.7.3: Contract Research Organizations
4. Market Trends and Forecast Analysis by Region
4.1: Global Genome Editing Market by Region
4.2: North American Genome Editing Market
4.2.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.2.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.2.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4: Market by Service: Contract and In-House
4.2.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.2.6: The United States Genome Editing Market
4.2.7: The Canadian Genome Editing Market
4.2.8: The Mexican Genome Editing Market
4.3: European Genome Editing Market
4.3.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.3.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.3.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4: Market by Service: Contract and In-House
4.2.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.3.6: The United Kingdom Genome Editing Market
4.3.7: The Spanish Genome Editing Market
4.3.8: The German Genome Editing Market
4.3.9: The French Genome Editing Market
4.4: APAC Genome Editing Market
4.4.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.4.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.4.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.4.4: Market by Service: Contract and In-House
4.4.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.4.6: The Chinese Genome Editing Market
4.4.7: The Indian Genome Editing Market
4.4.8: The Japanese Genome Editing Market
4.5: ROW Genome Editing Market
4.5.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.5.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.5.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.5.4: Market by Service: Contract and In-House
4.5.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.5.6: Brazilian Genome Editing Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Technology Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genome Editing Market by Technology
7.1.2: Growth Opportunities for the Global Genome Editing Market by Delivery Method
7.1.3: Growth Opportunities for the Global Genome Editing Market by Application
7.1.4: Growth Opportunities for the Global Genome Editing Market by Service
7.1.5: Growth Opportunities for the Global Genome Editing Market by End Use
7.1.6: Growth Opportunities for the Global Genome Editing Market by Region
7.2: Emerging Trends in the Global Genome Editing Market
7.3: Strategic Analysis
7.3.1: New Technology Development
7.3.2: Capacity Expansion of the Global Genome Editing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genome Editing Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Merck KGaA
8.2: Thermo Fisher Scientific
8.3: Horizon Discovery
8.4: Lonza
8.5: GenScript
8.6: Eurofins Scientific
8.7: Company 7
8.8: Company 8
8.9: Company 9
8.10: Company 10